Amanita mushrooms: Difference between revisions
ClaireLewis (talk | contribs) No edit summary |
Elcatracho (talk | contribs) |
||
| Line 1: | Line 1: | ||
==Background== | ==Background== | ||
''Amanita phalloides'' | *''Amanita phalloides'' | ||
*Not to be confused with ''Amanita muscaria'' | |||
[[File:Amanita phalloides.png|thumb|Amanita phalloides aka death cap]] | [[File:Amanita phalloides.png|thumb|Amanita phalloides aka death cap]] | ||
Revision as of 01:14, 6 February 2021
Background
- Amanita phalloides
- Not to be confused with Amanita muscaria
Clinical Features
Stage 1 (GI)
- Occurs 6-24hr after ingestion and lasts 12-24hr
- The later the onset of symptoms the better the outcome
- GI predominant symptoms:
- Abdominal pain, vomiting and diarrhea (which may become bloody)
Stage 2 (convalescent)
- Occurs 48hr after ingestion and lasts 12-24hr
- Symptoms subside and patient appears better
- Liver deteriorates silently and precipitously (LFTs begin to rise)
Stage 3 (failure)
- Occurs 2-4d after ingestion
- Fulminant liver failure
Differential Diagnosis
Causes of acute hepatitis
- Acetaminophen toxicity (most common cause of acute liver failure in the US[1])
- Viral hepatitis
- Toxoplasmosis
- Acute alcoholic hepatitis
- Toxins
- Ischemic hepatitis
- Autoimmune hepatitis
- Wilson's disease
Mushroom toxicity by Type
| Mushroom | Toxin | Pathologic Effect |
| Amanita | Amatoxin | Hepatotoxicity |
| Coprine | Disulfiram-like | |
| Crotinarius | Orellanine | Delayed renal failure |
| Gyromitra | Gyromitrin | Seizures |
| Ibotenic Acid | Anticholinergic | |
| Muscarine | Cholinergic | |
| Orellanin | Nephrotoxicity | |
| Psilocybin | Hallucinations |
SLUDGE Syndrome
- Carbamate toxicity
- Mushroom toxicity, especially:
- Organophosphate toxicity
- Nerve agent
- Nicotine toxicity (look alike)
- Acetylcholinesterase inhibitor overdose (e.g in myasthenia gravis or post anesthesia reversal)
Evaluation
Workup[2]
- Blood sugar
- BMP
- LFTs
- Lipase
- Coags, DIC labs
- CBC with differential
- LDH, haptoglobin, reticulocyte
- CK
- Thyroid studies
- Methemoglobin level
- Urine drug screen
- Urinalysis
Management
Immediate therapy
- Activated charcoal
- Some advocate repeated doses during the first 24hr
- Amatoxin undergoes enterohepatic circulation
- Some advocate repeated doses during the first 24hr
- Penicillin
- High doses 1 mil units/kg/d effective in animal studies (inhibits amatoxin uptake)
- Silibinin (milk thistle derivative)
- Mortality benefit
- Free radical scavenger used successfully in Europe
- 5mg/kg over 1 hr, then 25-50mg/kg/d[3]
- N-acetylcysteine admin much like in acetaminophen toxicity[4]
- Mortality benefit
- Load 150mg/kg IV over 15min in 200 cc D5W
- Then 50mg/kg in 500cc D5W over 4hrs
- Followed by 100mg/kg in 1000cc D5W over 16hrs
- Extracorporeal albumin dialysis[5]
- Allow hepatic regeneration or forestall transplantation
Ongoing therapy
- Glucose monitoring
- Hypoglycemia is one of the most common causes of death in early mushroom toxicity
- Liver/renal failure monitoring
- Serial LFTs, chem, coags
- Prepare for liver transplant
- Progressive coagulopathy, encephalopathy, renal failure are indications for transplant
Disposition
- Admit all suspected of ingesting amatoxin containing mushrooms for at least 48hr
- Referral to liver transplant service
See Also
External Links
References
- ↑ Ostapowicz G, Fontana RJ, Schiodt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002 Dec 17; 137(12): 947-54.
- ↑ Garcia J, Costa VM, Carvalho A, Baptista P, de Pinho PG, de Lourdes Bastos M, et al. Amanita phalloides poisoning: Mechanisms of toxicity and treatment. Food Chem Toxicol. 2015 Sep 12. 86:41-55.
- ↑ Saller, R., Brignoli, R., Melzer, J. and Meier, R. (2008) ‘An Updated Systematic Review with Meta-Analysis for the Clinical Evidence of Silymarin’, Forschende Komplementärmedizin / Research in Complementary Medicine, 15(1), pp. 9–20
- ↑ Lee DS et al. Amatoxin Toxicity Medication. July 21, 2015. http://emedicine.medscape.com/article/1008902-medication#2.
- ↑ Faybik, P., Hetz, H., Baker, A., Bittermann, C., Berlakovich, G., Werba, A., Krenn, C.-G. and Steltzer, H. (2003) ‘Extracorporeal albumin dialysis in patients with Amanita phalloides poisoning’, Liver International, 23pp. 28–33.